About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Management

 
 

3/28/2012 - Daxor Corporation Announces Year End 2011 Earnings

  

3/23/2012 - Daxor Announces That Shertech Pharmacy Acquires 2nd BVA-100 Blood Volume Analyzer

  

3/9/2012 - Daxor Announces Filing of Two Additional Patents for Updated Automated Blood Analyzer

  
 

______________________

 
     
  2011 Year End Earnings  
  2011 Form 10-K  
  September 2011 Form 10-Q  
  2011 Proxy Statement  
  DAXOR Corporation Newsletter; Issue 1, March 2010  
  2010 Annual Report  
 

 

 
Executive Team

Joseph Feldschuh, M.D.

President and CEO

Stephen Feldschuh

Vice President, Marketing and Development

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Gary Fischman, Ph.D.

Vice President, Research and Development
   
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company

Philip N. Hudson

Director of the Company

Mario Biaggi, Jr.

Director of the Company
   
Medical Advisory Board  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2012 DAXOR Corporation. All Rights Reserved.